Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Omkar Pharmachem Ltd has informed ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem Ltd has informed BSE that its Board of Directors will meet on 14 November 2025 at 5:00 PM at the registered office. The main agenda is to consider and approve the unaudited financial results for the quarter and half year ended 30 September 2025 (Q2 and H1 FY26). The company has also confirmed that the trading window for dealing in shares will remain closed till 16 November 2025 for designated persons and their immediate relatives. The intimation is filed under Regulation 29(1)(a) of SEBI LODR Regulations, 2015.
This is a routine regulatory intimation ahead of the upcoming results. Investors should watch for the Q2/H1 FY26 earnings announcement on or after 14 November 2025 for actual financial performance; no material decision is being taken at this stage.